Clinical Benefits in Responders (N=31)

CAM211 Clinical Benefit

• B-symptoms and/or fatigue

  • 100% (17/17) with baseline symptoms experienced resolution

• Massive splenomegaly (ɲ cm below costal margin-NCIWG)

  • 90% (9/10) experienced complete resolution

Previous slide

Next slide

Back to first slide

View graphic version